I agree that this site is using cookies. You can find further informations here.
X
Norrbacka, Kirsi
38  results:
Search for persons X
?
1

Utilities for Complications Associated with Type 2 Diabetes..:

Valentine, William J. ; Norrbacka, Kirsi ; Boye, Kristina S.
Advances in Therapy.  41 (2024)  7 - p. 2655-2681 , 2024
Link: https://doi.org/10.1007/..
 
?
2

Evaluating the Impact of Therapy on Quality of Life in Type..:

Valentine, William ; Norrbacka, Kirsi ; Boye, Kristina Secnik
Patient Related Outcome Measures.  13 (2022)  - p. 97-111 , 2022
Link: https://doi.org/10.2147/..
 
?
3

The PRIME Type 2 Diabetes Model: a novel, patient-level mod..:

Pollock, Richard F. ; Norrbacka, Kirsi ; Boye, Kristina S...
Journal of Medical Economics.  25 (2022)  1 - p. 393-402 , 2022
Link: https://doi.org/10.1080/..
 
?
4

Glucagon-Like Peptide 1 Receptor Agonists in Type 2 Diabete..:

Norrbacka, Kirsi ; Sicras-Mainar, Antoni ; Lebrec, Jeremie...
Diabetes Therapy.  12 (2021)  5 - p. 1535-1551 , 2021
Link: https://doi.org/10.1007/..
 
?
5

Health state utilities associated with treatment process fo..:

Matza, Louis S. ; Cutts, Katelyn N. ; Stewart, Katie D....
Quality of Life Research.  30 (2021)  7 - p. 2033-2043 , 2021
Link: https://doi.org/10.1007/..
 
?
6

Treatment Patterns and Persistence With GLP-1 RA Treatments..:

Zimner Rapuch, Sarah ; Divino, Victoria ; Norrbacka, Kirsi...
Diabetes Therapy.  12 (2021)  5 - p. 1553-1567 , 2021
Link: https://doi.org/10.1007/..
 
?
7

The Real-World Observational Prospective Study of Health Ou..:

García-Pérez, Luis-Emilio ; Boye, Kristina S. ; Rosilio, Myriam...
Diabetes Therapy.  12 (2021)  7 - p. 1929-1946 , 2021
Link: https://doi.org/10.1007/..
 
?
8

The Real-World Observational Prospective Study of Health Ou..:

Boye, Kristina S. ; Sapin, Hélène ; García-Pérez, Luis-Emilio...
Diabetes Therapy.  11 (2020)  10 - p. 2383-2399 , 2020
Link: https://doi.org/10.1007/..
 
?
9

Timing of GLP-1 Receptor Agonist Initiation for Treatment o..:

Boye, Kristina S. ; Stein, Dara ; Matza, Louis S....
Drugs in R&D.  19 (2019)  2 - p. 213-225 , 2019
Link: https://doi.org/10.1007/..
 
?
10

Patient preferences in Italy: health state utilities associ..:

Matza, Louis ; Boye, Kristina ; Jordan, Jessica...
Patient Preference and Adherence.  12 (2018)  - p. 971-979 , 2018
Link: https://doi.org/10.2147/..
 
?
11

Utilization Patterns of Glucagon-Like Peptide-1 Receptor Ag..:

Federici, Marco Orsini ; McQuillan, Janette ; Biricolti, Giovanni...
Diabetes Therapy.  9 (2018)  2 - p. 789-801 , 2018
Link: https://doi.org/10.1007/..
 
?
12

GLP-1 RA Treatment Patterns Among Type 2 Diabetes Patients ..:

Divino, Victoria ; DeKoven, Mitch ; Khan, Farhad Ali...
Diabetes Therapy.  8 (2017)  1 - p. 115-128 , 2017
Link: https://doi.org/10.1007/..
 
?
13

Schémas thérapeutiques et posologiques chez des patients av..:

Norrbacka, Kirsi ; Divino, Victoria ; DeKoven, Mitch.
Diabetes & Metabolism.  43 (2017)  2 - p. A35 , 2017
Link: https://doi.org/10.1016/..
 
?
14

The Cost-effectiveness of Dulaglutide 1.5mg versus Exenatid..:

Basson, Mickael ; Ntais, Dionysios ; Ayyub, Ruba...
Diabetes Therapy.  9 (2017)  1 - p. 13-25 , 2017
Link: https://doi.org/10.1007/..
 
?
15

The Prime Diabetes Model: Novel Methods for Estimating Long..:

Valentine, William J. ; Pollock, Richard F. ; Saunders, Rhodri...
Value in Health.  20 (2017)  7 - p. 985-991 , 2017
Link: https://doi.org/10.1016/..
 
1-15